Correspondence 0001104659-23-062099 from Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Date: May 18, 2023 · CIK: 0001454789 · Accession: 0001104659-23-062099
AI Filing Summary & Sentiment
File numbers found in text: 333-271848
Show Raw Text
CORRESP
1
filename1.htm
ASTRIA THERAPEUTICS, INC.
75 State Street
Suite 1400
Boston, Massachusetts 02109
May 18, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Astria Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-271848
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities
Act of 1933, as amended, Astria Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective
date of its Registration Statement on Form S-3 (File No. 333-271848), so that it may become effective at 4:30 p.m. Eastern time on May
23, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone
call to the staff.
Very truly yours,
ASTRIA THERAPEUTICS, INC.
By:
/s/ Ben Harshbarger
Name: Ben Harshbarger
Title: General Counsel and Corporate
Secretary
cc:
Rosemary G. Reilly, Esq.
Wilmer Cutler Pickering Hale and Dorr LLP